Feasibility of Electronic Directly Observed Therapy for Pediatric Leukemia Patients
Cohen A, Krishnamurti L, Creary S. Feasibility of Electronic Directly Observed Therapy for Pediatric Leukemia Patients. Blood 2012, 120: 3538. DOI: 10.1182/blood.v120.21.3538.3538.Peer-Reviewed Original ResearchAcute lymphoblastic leukemiaMedication adherenceMaintenance therapyAdherence surveyAdherence ratesHealthcare workersPediatric sickle cell populationMaintenance therapy phaseMedication adherence surveyWeekly oral methotrexateDisease-free survivalAnti-retroviral therapyPediatric leukemia patientsHigher adherence ratesNon-adherence ratesRisk of relapseSelf-reported adherenceCommon pediatric cancerSickle cell populationEnd of studyGood overall adherenceYears of ageIntravenous vincristineMMAS-4Month regimen